the-first-vaccine-against-monkeypox-has-passed-preliminary-qualification

The first vaccine against monkeypox has passed preliminary qualification

 • 14042 переглядiв

The first vaccine against monkeypox - MVA-BN - has passed preliminary qualification by the WHO, the World Health Organization (WHO) said in a statement, UNN reports .

Details

The approval of the prequalification is expected to facilitate timely and expanded access to the vaccine in communities with acute need, reduce transmission and help contain the outbreak.

WHO's assessment for prequalification is based on information provided by the manufacturer, Bavarian Nordic A/S, and a review by the European Medicines Agency, the regulatory authority that registers the vaccine.

Is there a global pandemic: infectious disease specialist Olga Golubovskaya talks about forecasts for it9/13/24, 12:36 PM • [views_32981]

This first pre-qualification of a smallpox vaccine is an important step in our fight against the disease, both in the context of current outbreaks in Africa and in the future

- WHO Director-General Tedros Adanom Ghebreyesus said. 

MVA-BN vaccine can be administered to people over 18 years of age as a 2-dose injection at 4-week intervals. After preliminary cold storage, the vaccine can be stored at 2-8 °C for up to 8 weeks.

WHO: $135 million needed to tackle monkeypox outbreak24.08.24, 06:54 • [views_20909]

The WHO Strategic Advisory Group of Experts (SAGE) on Immunization reviewed all available evidence and recommended that MVA-BN be used in the context of a smallpox outbreak for persons at high risk of infection. Although MVA-BN is not currently licensed for persons under 18 years of age, it may be off-label in infants, children and adolescents, as well as in pregnant and immunocompromised individuals. This means that the use of the vaccine is recommended in an outbreak situation where the benefits of vaccination outweigh the potential risks.

According to research, a single dose of MVA-BN vaccine administered before infection is 76% effective in protecting people from monkeypox. In the case of two doses of the vaccine, the figure increases to 82%. 

Addendum

More than 120 countries have confirmed more than 103,000 cases of monkeypox since the global outbreak began in 2022. In 2024 alone, there were 25,237 suspected and confirmed cases and 723 deaths from various outbreaks in 14 countries in the African region (based on data as of September 8, 2024).

Another 1,200 cases of monkeypox detected in Africa over the week18.08.24, 20:37 • [views_26347]

Tatiana KraevskayaHealth
    Popular
    Netflix announced it is buying Warner Bros. and HBO

     • 11795 переглядiв

    St. Nicholas Day: traditions, customs, and prohibitions

     • 23036 переглядiв

    Six regions switched to emergency power outages - Ukrenergo

     • 24619 переглядiв

    News by theme
    The first vaccine against monkeypox has passed preliminary qualification

     • 14042 переглядiв

    Bitcoin fell to $57 thousand amid rumors of a rate cut

     • 16997 переглядiв

    Investigation of large-scale tax evasion scheme at Chernivtsi customs completed

     • 11845 переглядiв

    Russian air strike on Yampol: two dead, no electricity supply

     • 13806 переглядiв